Nektar Therapeutics | NKTR - Pre Tax Profit

Stock Price
67.03
Daily Change
11.03 19.70%
Monthly
72.89%
Yearly
511.31%
Q1 Forecast
1.21

Nektar Therapeutics reported $-37.05M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Amgen USD 3.92B 2.35B Sep/2025
Baxter International USD 121M 12M Sep/2025
BioCryst Pharmaceuticals USD -86.95M 73.5M Dec/2024
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Cipla INR 11.69B 6.85B Dec/2025
Dr.Reddys Laboratories INR 15.68B 2.38B Dec/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Exelixis USD 252.69M 275K Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Grifols EUR 66.98M 19.92M Jun/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Incyte USD 482.31M 75.7M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024
MacroGenics USD 16.82M 52.97M Sep/2025
Merck USD 6.74B 22M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Takeda JPY 133.86B 105.69B Dec/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
Xencor USD -6.03M 25.05M Sep/2025